FDANonrulemakingFDA-2019-D-1615
Who commented on this docket
Instructions for Use -- Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products -- Content and Format; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Instructions for Use -- Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products -- Content and Format; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2520d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 2520d ago
Commenters (1)
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.